Showing results (1-10 of 44) with videos related to
Sort By:
Pageof 5
Gastroenterologie Clinique Et Biologique|June 23, 2009
[Nonalcoholic fatty liver disease: 30 years research changed NASH]V Ratziu, T PoynardCanadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|July 11, 2000
Appropriateness of liver biopsyT Poynard, V Ratziu, P BedossaLa Revue Du Praticien|July 25, 2000
[Treatment and prevention of hepatitis C]T Poynard, V Ratziu, Y Benhamou, et al.Journal of Neurology, Neurosurgery, and Psychiatry|November 14, 2006
Safety and tolerability of adjunctive tolcapone treatment in patients with early Parkinson's diseaseA J Lees, V Ratziu, E Tolosa, et al.Journal of Hepatology|January 6, 2000
Effects of interferon therapy in "non responder" patients with chronic hepatitis CT Poynard, J Moussali, V Ratziu, et al.Alimentary Pharmacology & Therapeutics|October 18, 2005
Review article: an unexpected virus-host interaction--the hepatitis C virus-diabetes linkV Ratziu, A Heurtier, L Bonyhay, et al.Clinics in Liver Disease|April 9, 2001
Effect of interferon therapy on the natural history of hepatitis C virus-related cirrhosis and hepatocellular carcinomaT Poynard, J Moussalli, V Ratziu, et al.Hepatology (Baltimore, Md.)|May 1, 1996
Binding of apolipoprotein A-I and acetaldehyde-modified apolipoprotein A-I to liver extracellular matrixV Paradis, P Mathurin, V Ratziu, et al.Clinics and Research in Hepatology and Gastroenterology|June 3, 2011
Progression from isolated steatosis to steatohepatitis and fibrosis in nonalcoholic fatty liver diseaseR Pais, A Pascale, L Fedchuck, et al.Pageof 5